| Serial Number | 79241700 |
| Word Mark | GC |
| Filing Date | Thursday, May 17, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 11, 2020 |
| Registration Number | 6121018 |
| Registration Date | Tuesday, August 11, 2020 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 26, 2020 |
| Description of Mark | The mark consists of a stylized rounded cross with the top and right arms in red fading toward the middle to orange then to yellow, and the left and lower arms in green; to the right of the cross are the letters "GC" in deep blue. |
| Goods and Services | Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; medicated plasters; vaccines; biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors |
| Indication of Colors claimed | The color(s) red, orange, yellow, green and deep blue is/are claimed as a feature of the mark. |
| Goods and Services | Retail store services featuring pharmaceutical preparations for the treatment of cells; retail store services featuring medical instruments; retail store services featuring medical apparatus; retail store services featuring biological preparations for medical purposes; retail store services featuring medical genetic analyzer; retail and wholesale store services featuring pharmaceutical preparations; import-export agency services; retail store services featuring electromedical diagnostic instruments; wholesale store services featuring pharmaceutical preparations for the treatment of cells; wholesale store services featuring medical instruments; wholesale store services featuring medical apparatus; wholesale store services featuring biological preparations for medical purposes; wholesale store services featuring medical genetic analyzer; wholesale store services featuring electromedical diagnostic instruments; all the foregoing excluding services in the field of industrial, institutional, commercial and janitorial equipment and supplies |
| Goods and Services | Medical services, namely, the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow for medical preventive, diagnostic and treatment purposes; medical examination services; health clinic services, namely, medical clinics; analysis of human tissues for medical diagnosis purposes and treatment; medical consultancy for selecting appropriate medicines; human tissue bank services; medical services, namely, clinical pathology examination; cord blood bank services; health center services; medical and pharmaceutical consultancy; medical and health care services; pharmacy services, namely, dispensing of pharmaceuticals; consultancy and information services relating to the dispensing of pharmaceutical products; dispensing of pharmaceuticals; preparation and dispensing of medications; information services relating to utilization of medical products in connection with the provision of medical services; medical and health services relating to DNA, genetics and genetic testing; managed health care services |
| Goods and Services | Medical apparatus and instruments for use in performing biopsies; medical testing apparatus for medical purposes, namely, medical apparatus for testing DNA and RNA samples; medical diagnostic apparatus and instruments for immunodiagnosis and molecular diagnosis; electromedical diagnostic instruments for immunodiagnosis and molecular diagnosis; apparatus for use in medical analysis, namely, medical apparatus for blood test; medical health signal measuring instruments for monitoring vital signs; wireless bio-signal measuring instruments for medical purposes, namely, biofeedback sensors; precision sensors for medical use, namely, heart rhythm sensors, respiratory sensors and biofeedback sensors; laser machining tools for medical use, namely, lasers for surgical and medical use; genetic testing apparatus, namely, apparatus for DNA and RNA testing for medical purposes |
| Goods and Services | Research and development of vaccines and medicines; conducting clinical studies of medicines for medical research purposes; clinical research in the nature of performing biopsies for medical research; product research and development of medical products; conducting technical project studies, namely, engineering services in the nature of technical project planning and design engineering of medical products; testing, inspection or research of pharmaceuticals; scientific research relating to biology; scientific research in the field of genetic engineering; research and development of technology for biotechnology; scientific research in the fields of biomedicine; laboratory research in the field of biology; product development of cell therapy products; drug discovery services; research and development in the pharmaceutical and biotechnology fields; scientific research in the field of gene analysis; medical studies, namely, medical laboratory services; research and development of technology for medicinal chemical manufacturing; medical research services relating to clinical data |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 9, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 9, 2018 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 9, 2018 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 9, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 9, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Green Cross Holdings Corporation |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Green Cross Holdings Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Green Cross Holdings Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Tuesday, October 9, 2018 | ASSIGNED TO EXAMINER |
| Thursday, September 27, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, October 9, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, October 13, 2018 | APPLICATION FILING RECEIPT MAILED |
| Thursday, October 18, 2018 | NON-FINAL ACTION WRITTEN |
| Friday, October 19, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, November 2, 2018 | REFUSAL PROCESSED BY MPU |
| Friday, November 2, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, November 24, 2018 | REFUSAL PROCESSED BY IB |
| Monday, April 22, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, April 22, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, May 1, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 8, 2019 | ASSIGNED TO LIE |
| Wednesday, May 8, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 8, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 30, 2019 | SUSPENSION LETTER WRITTEN |
| Thursday, May 30, 2019 | LETTER OF SUSPENSION E-MAILED |
| Thursday, May 30, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, July 23, 2019 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Tuesday, July 30, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 30, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 2, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 6, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 30, 2019 | NON-FINAL ACTION WRITTEN |
| Friday, December 6, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 10, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 10, 2020 | NOTIFICATION PROCESSED BY IB |
| Tuesday, January 14, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, February 19, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, December 25, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 25, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, December 25, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, January 14, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 19, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 19, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 19, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 4, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, March 10, 2020 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, February 19, 2020 | WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST |
| Wednesday, February 19, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, February 19, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 26, 2020 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, March 4, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, April 13, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, April 13, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Monday, April 13, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, April 21, 2020 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, May 6, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, May 6, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, May 6, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, May 11, 2020 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Friday, March 20, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Thursday, April 2, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, April 13, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Monday, April 13, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 26, 2020 | PUBLISHED FOR OPPOSITION |
| Friday, June 12, 2020 | POST PUBLICATION AMENDMENT - ENTERED |
| Tuesday, August 11, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, December 3, 2020 | FINAL DISPOSITION PROCESSED |
| Thursday, December 3, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Saturday, December 26, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, May 26, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, June 11, 2020 | ASSIGNED TO PETITION STAFF |
| Friday, June 12, 2020 | NOTIFICATION PROCESSED BY IB |
| Wednesday, November 11, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, August 11, 2025 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |